Rational design of flavivirus E protein vaccine optimizes immunogenicity and mitigates antibody dependent enhancement risk

Nature·Dec 22

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

Researchers are exploring the rational design of a flavivirus E protein vaccine to optimize its effectiveness and reduce the risk of antibody dependent enhancement. Various approaches are being investigated, including targeting specific virus envelope domains and using protein engineering strategies. Studies on different flaviviruses, such as Zika, West Nile, and Dengue, are informing the development of candidate vaccines.

Full coverage

Targeting the Zika virus envelope domains I and III as a recombinant vaccine protects mice from lethal challenge

Nature·Apr 14

Identification of the flavivirus conserved residues in the envelope protein hinge region for the rational design of a candidate West Nile live-attenuated vaccine

Nature·Nov 6

A VLPs based vaccine protects against Zika virus infection and prevents cerebral and testicular damage | npj Vaccines

Nature·May 27

Protein engineering strategies for rational immunogen design - npj Vaccines

Nature·Dec 17

Assembly-defective Tembusu virus ectopically expressing capsid protein is an approach for live-attenuated flavivirus vaccine development

Nature·May 12

From promise to pitfalls: immunological lessons from dengue vaccines and their implications

Nature·Feb 14

Synthetic biology-inspired development of live attenuated influenza vaccines

Nature·Aug 27

Temperature-dependent folding allows stable dimerization of secretory and virus-associated E proteins of Dengue and Zika viruses in mammalian cells

Nature·Apr 19

View original report at Nature ↗

Fetching the latest headlines…